Atlas Trials

Dupixent and Narrowband UVB for Atopic Dermatitis

Clinical trial NCT05285839 · RECRUITING

Trial details

NCT number
NCT05285839
Sponsor
Psoriasis Treatment Center of Central New Jersey
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2022-04-19
Primary completion
2024-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.